drugset / Trial / NCT01907867
Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin
Non-randomizedCrossoverOpen-labelTreatment
Summary
This study investigates the safety, tolerability, and PK profile of finafloxacin as a novel fluoroquinolone and a potential therapeutic agent for lower respiratory infections such as bacterial pneumonia. A comparison of the PK profile of finafloxacin in plasma and lung ELF using different bronchoscopic ELF sampling techniques (BMS and BAL) is conducted.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Finafloxacin | Small molecule | 800 mg | Oral |
Indications
No indication recorded.